{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:51:58Z","timestamp":1788983518709,"version":"build-2803163510"},"reference-count":108,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jctejournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical &amp; Translational Endocrinology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.jcte.2021.100274","type":"journal-article","created":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T12:04:10Z","timestamp":1636200250000},"page":"100274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Amino acid sequence homology between thyroid autoantigens and central nervous system proteins: Implications for the steroid-responsive encephalopathy associated with autoimmune thyroiditis"],"prefix":"10.1016","volume":"26","author":[{"given":"Salvatore","family":"Benvenga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poupak","family":"Fallahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Bonanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelo","family":"Rodolico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Guarneri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcte.2021.100274_b0005","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0140-6736(66)92876-5","article-title":"Hashimoto\u2019s disease and encephalopathy","volume":"288","author":"Brain","year":"1966","journal-title":"Lancet"},{"key":"10.1016\/j.jcte.2021.100274_b0010","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1089\/105072502760043477","article-title":"Rarity of encephalopathy associated with autoimmune thyroiditis: a case series from Mayo Clinic from 1950 to 1996","volume":"12","author":"Sawka","year":"2002","journal-title":"Thyroid"},{"key":"10.1016\/j.jcte.2021.100274_b0015","doi-asserted-by":"crossref","unstructured":"Melcescu E, Horton WB, Pitman KT, Vijayakumar V, Koch CA. Euthyroid Graves' orbitopathy and incidental papillary thyroid microcarcinoma. Hormones (Athens) 2013;12:298-304. 10.14310\/horm.2002.1414.","DOI":"10.14310\/horm.2002.1414"},{"key":"10.1016\/j.jcte.2021.100274_b0020","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/SMJ.0000000000000038","article-title":"Graves orbitopathy: update on diagnosis and therapy","volume":"107","author":"Melcescu","year":"2014","journal-title":"South Med J"},{"key":"10.1016\/j.jcte.2021.100274_b0025","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/BF00900946","article-title":"Encephalopathy associated with Hashimoto thyroiditis: diagnosis and treatment","volume":"243","author":"Kothbauer-Margreiter","year":"1996","journal-title":"J Neurol"},{"key":"10.1016\/j.jcte.2021.100274_b0030","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0014-5793(02)03307-0","article-title":"Proteomic analysis of human brain identifies alpha-enolase as a novel autoantigen in Hashimoto's encephalopathy","volume":"528","author":"Ochi","year":"2002","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jcte.2021.100274_b0035","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jneuroim.2007.01.018","article-title":"High prevalence of serum autoantibodies against the amino terminal of alpha-enolase in Hashimoto's encephalopathy","volume":"185","author":"Yoneda","year":"2007","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jcte.2021.100274_b0040","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jneuroim.2008.02.015","article-title":"Novel autoantigens recognized by CSF IgG from Hashimoto's encephalitis revealed by a proteomic approach","volume":"196","author":"Gini","year":"2008","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jcte.2021.100274_b0045","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s11011-017-0076-3","article-title":"Expression of thyroid-stimulating hormone receptors and thyroglobulin in limbic regions in the adult human brain","volume":"33","author":"Naicker","year":"2018","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.jcte.2021.100274_b0050","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1001\/archneur.60.2.164","article-title":"Hashimoto encephalopathy. syndrome or myth?","volume":"60","author":"Chong","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jcte.2021.100274_b0055","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1212\/WNL.54.3.769","article-title":"Hashimoto encephalopathy: a brainstem vasculitis?","volume":"54","author":"Nolte","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jcte.2021.100274_b0060","unstructured":"Shibata N, Yamamoto Y, Sunami N, Suga M, Yamashita Y. Isolated angiitis of the CNS associated with Hashimoto\u2019s disease. Rinsho Shinkeigaku 1992;32:191-8. N\/A."},{"key":"10.1016\/j.jcte.2021.100274_b0065","unstructured":"Perrot X, Giraud P, Biacabe AG, Perret-Liaudet A, Borson-Chazot F, Gray F, et al. Hashimoto's encephalopathy: an anatomicoclinical observation. Rev Neurol (Paris) 2002;158:461-6. RN-04-2002-158-4-0035-3787-101019-ART8."},{"key":"10.1016\/j.jcte.2021.100274_b0070","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jns.2003.08.005","article-title":"Anti-neuronal autoantibody in Hashimoto's encephalopathy: neuropathological, immunohistochemical, and biochemical analysis of two patients","volume":"217","author":"Oide","year":"2004","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jcte.2021.100274_b0075","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/jnnp.73.5.601-a","article-title":"Hashimoto\u2019s encephalopathy mimicking Creutzfeldt-Jakob disease: brain biopsy findings","volume":"73","author":"Doherty","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jcte.2021.100274_b0080","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1212\/01.WNL.0000090462.62087.A1","article-title":"Hashimoto's encephalopathy: postmortem findings after fatal status epilepticus","volume":"61","author":"Duffey","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jcte.2021.100274_b0085","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/archneur.63.2.197","article-title":"Steroid-responsive encephalopathy associated with autoimmune thyroiditis","volume":"63","author":"Castillo","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jcte.2021.100274_b0090","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.pediatrneurol.2011.04.012","article-title":"Central nervous system vasculitis with positive antithyroid antibodies in an adolescent boy","volume":"45","author":"Tsai","year":"2011","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.jcte.2021.100274_b0095","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jns.2018.09.008","article-title":"Hashimoto's encephalopathy mimicking a brain tumor and its pathological findings: A case report","volume":"394","author":"Uwatoko","year":"2018","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jcte.2021.100274_b0100","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/ccr3.1306","article-title":"Hashimoto's encephalopathy \u2013 presenting with epilepsia partialis continua and a frontal lobe lesion","volume":"6","author":"Rukmangadachar","year":"2018","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.jcte.2021.100274_b0105","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/NRL.0b013e3182173341","article-title":"A case of Hashimoto encephalopathy: clinical manifestation, imaging, pathology, treatment, and prognosis","volume":"17","author":"Zhao","year":"2011","journal-title":"Neurologist"},{"key":"10.1016\/j.jcte.2021.100274_b0110","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1055\/s-0031-1277137","article-title":"Primary hypothyroidism associated with acute mania: case series and literature review","volume":"119","author":"Khemka","year":"2011","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.jcte.2021.100274_b0115","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bbi.2020.07.039","article-title":"Association of thyroid peroxidase antibodies with anti-neuronal surface antibodies in health, depression and schizophrenia - Complementary linkage with somatic symptoms of major depression","volume":"90","author":"Steiner","year":"2020","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.jcte.2021.100274_b0120","doi-asserted-by":"crossref","first-page":"453","DOI":"10.7326\/M18-0284","article-title":"Thyroidectomy versus medical management for euthyroid patients with Hashimoto disease and persisting symptoms: a randomized trial","volume":"170","author":"Guldvog","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jcte.2021.100274_b0125","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2741\/4804","article-title":"Homology between TSH-R\/Tg\/TPO and Hashimoto's encephalopathy autoantigens","volume":"25","author":"Benvenga","year":"2020","journal-title":"Front Biosci (Landmark Ed)"},{"key":"10.1016\/j.jcte.2021.100274_b0130","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1089\/thy.2006.16.225","article-title":"Human thyroid autoantigens and proteins of Yersinia and Borrelia share amino acid sequence homology that includes binding motifs to HLA-DR molecules and T-cell receptor","volume":"16","author":"Benvenga","year":"2006","journal-title":"Thyroid"},{"key":"10.1016\/j.jcte.2021.100274_b0135","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1089\/thy.2010.0364","article-title":"Bioinformatics support the possible triggering of autoimmune thyroid diseases by Yersinia enterocolitica outer membrane proteins homologous to the human TSH receptor","volume":"21","author":"Guarneri","year":"2011","journal-title":"Thyroid"},{"key":"10.1016\/j.jcte.2021.100274_b0140","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12020-010-9410-9","article-title":"Injections of Clostridium botulinum neurotoxin A may cause thyroid complications in predisposed persons based on molecular mimicry with thyroid autoantigens","volume":"39","author":"Gregoric","year":"2011","journal-title":"Endocrine"},{"key":"10.1016\/j.jcte.2021.100274_b0145","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1089\/thy.2013.0170","article-title":"Autoimmune thyroid disease elicited by NY-ESO-1 vaccination","volume":"24","author":"Vita","year":"2014","journal-title":"Thyroid"},{"key":"10.1016\/j.jcte.2021.100274_b0150","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1007\/s12020-015-0767-7","article-title":"Graves' disease precipitated by rickettsial infection","volume":"50","author":"Marangou","year":"2015","journal-title":"Endocrine"},{"key":"10.1016\/j.jcte.2021.100274_b0155","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s11154-016-9363-2","article-title":"Molecular mimicry and autoimmune thyroid disease","volume":"17","author":"Benvenga","year":"2016","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.jcte.2021.100274_b0160","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1093\/nar\/25.17.3389","article-title":"Gapped BLAST and PSI-BLAST: a new generation of protein database search programs","volume":"25","author":"Altschul","year":"1997","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jcte.2021.100274_b0165","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2567.2004.01861.x","article-title":"Thyroglobulin as an autoantigen: what can we learn about immunopathogenicity from the correlation of antigenic properties with protein structure?","volume":"112","author":"Gentile","year":"2004","journal-title":"Immunology"},{"key":"10.1016\/j.jcte.2021.100274_b0170","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1740-2557-2-2","article-title":"Localization of the immunodominant region on human thyroid peroxidase in autoimmune thyroid diseases: an update","volume":"2","author":"Bresson","year":"2005","journal-title":"J Autoimmune Dis"},{"key":"10.1016\/j.jcte.2021.100274_b0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142615","article-title":"Modelling of thyroid peroxidase reveals insights into its enzyme function and autoantigenicity","volume":"10","author":"Le","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcte.2021.100274_b0180","unstructured":"National Institute of Allergy and Infectious Diseases. The Immune Epitope Database (IEDB), http:\/\/www.iedb.org; 2020 [accessed 8 October 2020]."},{"issue":"D1","key":"10.1016\/j.jcte.2021.100274_b0185","first-page":"D77","article-title":"Expression Atlas update: from tissues to single cells","volume":"48","author":"Papatheodorou","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jcte.2021.100274_b0190","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3389\/fimmu.2017.00514","article-title":"Reactivity to novel autoantigens in patients with coexisting central nervous system demyelinating disease and autoimmune thyroid disease","volume":"8","author":"Greer","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcte.2021.100274_b0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137927","article-title":"Two of them do it better: novel serum biomarkers improve autoimmune hepatitis diagnosis","volume":"10","author":"Mazzara","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcte.2021.100274_b0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003742","article-title":"Potential relevance of alpha(1)-adrenergic receptor autoantibodies in refractory hypertension","volume":"3","author":"Wenzel","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcte.2021.100274_b0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009409","article-title":"Alpha1A-adrenergic receptor-directed autoimmunity induces left ventricular damage and diastolic dysfunction in rats","volume":"5","author":"Wenzel","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcte.2021.100274_b0210","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0165-5728(03)00252-2","article-title":"Autoantibodies against four kinds of neurotransmitter receptors in psychiatric disorders","volume":"141","author":"Tanaka","year":"2003","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jcte.2021.100274_b0215","first-page":"225","article-title":"Autoantibodies against muscarinic cholinergic receptor in chronic fatigue syndrome","volume":"12","author":"Tanaka","year":"2003","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.jcte.2021.100274_b0220","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1182\/blood-2002-01-0055","article-title":"Anti-mu-opioid-receptor IgG antibodies are commonly present in serum from healthy blood donors: evidence for a role in apoptotic immune cell death","volume":"100","author":"Mac\u00e9","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jcte.2021.100274_b0225","doi-asserted-by":"crossref","first-page":"20079","DOI":"10.1074\/jbc.274.29.20079","article-title":"Morphine-like activity of natural human IgG autoantibodies is because of binding to the first and third extracellular loops of the mu-opioid receptor","volume":"274","author":"Mac\u00e9","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jcte.2021.100274_b0230","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/(SICI)1521-4141(199903)29:03<997::AID-IMMU997>3.0.CO;2-1","article-title":"Isolation and characterization of natural human IgG with a morphine-like activity","volume":"29","author":"Mac\u00e9","year":"1999","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jcte.2021.100274_b0235","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1468-3083.2012.04501.x","article-title":"Melanocyte antigen-specific antibodies cannot be used as markers for recent disease activity in patients with vitiligo","volume":"27","author":"Kroon","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jcte.2021.100274_b0240","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/jid.2010.341","article-title":"Vitiligo autoantigen VIT75 is identified as lamin A in vitiligo by serological proteome analysis based on mass spectrometry","volume":"131","author":"Li","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jcte.2021.100274_b0245","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1600-0625.2008.00813.x","article-title":"Mapping of melanin-concentrating hormone receptor 1 B cell epitopes predicts two major binding sites for vitiligo patient autoantibodies","volume":"18","author":"Gavalas","year":"2009","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jcte.2021.100274_b0250","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1046\/j.1523-1747.2003.12494.x","article-title":"Autoantibodies in vitiligo patients recognize multiple domains of the melanin-concentrating hormone receptor","volume":"121","author":"Gottumukkala","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jcte.2021.100274_b0255","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1172\/JCI0214643","article-title":"The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo","volume":"109","author":"Kemp","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jcte.2021.100274_b0260","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0090-1229(87)90109-7","article-title":"Studies on the formation of glomerular immune deposits in brown Norway rats injected with mercuric chloride","volume":"45","author":"Fukatsu","year":"1987","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.jcte.2021.100274_b0265","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/ki.1990.195","article-title":"Entactin: a possible auto-antigen in the pathogenesis of non-Goodpasture anti-GBM nephritis","volume":"38","author":"Saxena","year":"1990","journal-title":"Kidney Int"},{"key":"10.1016\/j.jcte.2021.100274_b0270","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/ndt\/6.6.389","article-title":"Circulating autoantibodies in patients with extracapillary glomerulonephritis","volume":"6","author":"Saxena","year":"1991","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jcte.2021.100274_b0275","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/ki.1991.126","article-title":"Circulating anti-entactin antibodies in patients with glomerulonephritis","volume":"39","author":"Saxena","year":"1991","journal-title":"Kidney Int"},{"key":"10.1016\/j.jcte.2021.100274_b0280","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3109\/02713689409047010","article-title":"Ultrastructural and immunocytochemical studies of iris vessels in rats with experimental autoimmune uveoretinitis","volume":"13","author":"Wang","year":"1994","journal-title":"Curr Eye Res."},{"key":"10.1016\/j.jcte.2021.100274_b0285","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1136\/ard.53.10.659","article-title":"Significance of anti-entactin antibodies in patients with systemic lupus erythematosus and related disorders","volume":"53","author":"Saxena","year":"1994","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jcte.2021.100274_b0290","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2796.1995.tb00912.x","article-title":"Circulating autoantibodies as serological markers in the differential diagnosis of pulmonary renal syndrome","volume":"238","author":"Saxena","year":"1995","journal-title":"J Intern Med"},{"key":"10.1016\/j.jcte.2021.100274_b0295","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1172\/JCI23587","article-title":"Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays","volume":"115","author":"Li","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jcte.2021.100274_b0300","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1136\/annrheumdis-2014-205396","article-title":"Aicardi-Gouti\u00e8res syndrome harbours abundant systemic and brain-reactive autoantibodies","volume":"74","author":"Cuadrado","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jcte.2021.100274_b0305","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1742-2094-10-128","article-title":"A novel autoantibody against ephrin type B receptor 2 in acute necrotizing encephalopathy","volume":"10","author":"Shirai","year":"2013","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.jcte.2021.100274_b0310","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160283","article-title":"Anti-ephrin type-B receptor 2 (EphB2) and anti-Three Prime Histone mRNA EXonuclease 1 (THEX1) autoantibodies in scleroderma and lupus","volume":"11","author":"Azzouz","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcte.2021.100274_b0315","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.autrev.2010.09.003","article-title":"Anti-fibrillin-1 autoantibodies in normal pregnancy and recurrent pregnancy loss","volume":"10","author":"Atanasova","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jcte.2021.100274_b0320","first-page":"273","article-title":"Autoantibodies in systemic sclerosis: clinical interest and diagnosis approach","volume":"67","author":"Admou","year":"2009","journal-title":"Ann Biol Clin (Paris)"},{"key":"10.1016\/j.jcte.2021.100274_b0325","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10354-007-0451-5","article-title":"Autoantibodies in systemic sclerosis (scleroderma): clues for clinical evaluation, prognosis and pathogenesis","volume":"158","author":"Grassegger","year":"2008","journal-title":"Wien Med Wochenschr"},{"key":"10.1016\/j.jcte.2021.100274_b0330","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.4049\/jimmunol.175.7.4555","article-title":"Autoantibodies to fibrillin-1 activate normal human fibroblasts in culture through the TGF-beta pathway to recapitulate the \u201cscleroderma phenotype\u201d","volume":"175","author":"Zhou","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.jcte.2021.100274_b0335","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.vph.2005.06.005","article-title":"Serum fibrillin-antifibrillin immune complexes among diabetic children","volume":"43","author":"Nicoloff","year":"2005","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.jcte.2021.100274_b0340","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000049191","article-title":"Anti-fibrillin-1 autoantibodies in systemic sclerosis are GM and KM allotype-restricted","volume":"18","author":"Pandey","year":"2001","journal-title":"Exp Clin Immunogenet"},{"key":"10.1016\/j.jcte.2021.100274_b0345","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1002\/1529-0131(200011)43:11<2464::AID-ANR13>3.0.CO;2-F","article-title":"Autoantibodies to fibrillin 1 in systemic sclerosis: ethnic differences in antigen recognition and lack of correlation with specific clinical features or HLA alleles","volume":"43","author":"Tan","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jcte.2021.100274_b0350","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1046\/j.1365-3083.2000.00733.x","article-title":"Fine specificity of anti-fibrillin-1 autoantibodies in primary pulmonary hypertension syndrome","volume":"51","author":"Morse","year":"2000","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jcte.2021.100274_b0355","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1006\/jaut.2000.0362","article-title":"Kinetics of anti-fibrillin-1 autoantibodies in MCTD and CREST syndrome","volume":"14","author":"Lundberg","year":"2000","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jcte.2021.100274_b0360","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1002\/1529-0131(199912)42:12<2656::AID-ANR22>3.0.CO;2-N","article-title":"Autoantibodies to the extracellular matrix microfibrillar protein, fibrillin 1, in patients with localized scleroderma","volume":"42","author":"Arnett","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jcte.2021.100274_b0365","doi-asserted-by":"crossref","unstructured":"Tan FK, Arnett FC, Antohi S, Saito S, Mirarchi A, Spiera H, et al. Autoantibodies to the extracellular matrix microfibrillar protein, fibrillin-1, in patients with scleroderma and other connective tissue diseases. J Immunol 1999;163:1066-72. N\/A.","DOI":"10.4049\/jimmunol.163.2.1066"},{"key":"10.1016\/j.jcte.2021.100274_b0370","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.2169\/internalmedicine.4708-20","article-title":"A patient with fulminant myasthenia gravis is seropositive for both AChR and LRP4 antibodies, complicated by autoimmune polyglandular syndrome type 3","volume":"59","author":"Inoue","year":"2020","journal-title":"Intern Med"},{"key":"10.1016\/j.jcte.2021.100274_b0375","article-title":"Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: autoantibody profiles and clinical features","volume":"13","author":"Park","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcte.2021.100274_b0380","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.2169\/internalmedicine.0966-18","article-title":"Late-onset myasthenia gravis accompanied by amyotrophic lateral sclerosis with antibodies against the acetylcholine receptor and low-density lipoprotein receptor-related protein 4","volume":"57","author":"Ohnari","year":"2018","journal-title":"Intern Med"},{"key":"10.1016\/j.jcte.2021.100274_b0385","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/WNO.0000000000000499","article-title":"Low-density lipoprotein receptor-related protein 4-positive myasthenia gravis in a double-seronegative, electromyography-negative patient","volume":"37","author":"Kruger","year":"2017","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.jcte.2021.100274_b0390","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.nmd.2017.06.001","article-title":"Double-seropositive myasthenia gravis with acetylcholine receptor and low-density lipoprotein receptor-related protein 4 antibodies associated with invasive thymoma","volume":"27","author":"Ishikawa","year":"2017","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.jcte.2021.100274_b0395","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/mus.25591","article-title":"Anti-LRP4 autoantibodies in Chinese patients with myasthenia gravis","volume":"56","author":"Li","year":"2017","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jcte.2021.100274_b0400","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12883-016-0758-1","article-title":"Myasthenic symptoms in anti-low- density lipoprotein receptor-related protein 4 antibody-seropositive amyotrophic lateral sclerosis: two case reports","volume":"16","author":"Takahashi","year":"2016","journal-title":"BMC Neurol"},{"key":"10.1016\/j.jcte.2021.100274_b0405","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135378","article-title":"Flow cytofluorimetric analysis of anti-LRP4 (LDL receptor-related protein 4) autoantibodies in Italian patients with myasthenia gravis","volume":"10","author":"Marino","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcte.2021.100274_b0410","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jaut.2013.12.004","article-title":"A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis","volume":"52","author":"Zisimopoulou","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jcte.2021.100274_b0415","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.nmd.2013.03.013","article-title":"Double seronegative myasthenia gravis with anti-LRP 4 antibodies","volume":"23","author":"Zouvelou","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.jcte.2021.100274_b0420","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.5692\/clinicalneurol.52.1303","article-title":"Progress of myasthenia gravis: discovery of Lrp4 antibodies","volume":"52","author":"Motomura","year":"2012","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.jcte.2021.100274_b0425","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ana.22312","article-title":"Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis","volume":"69","author":"Higuchi","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jcte.2021.100274_b0430","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115424","article-title":"Crossreactive autoantibodies directed against cutaneous and joint antigens are present in psoriatic arthritis","volume":"9","author":"Dolcino","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcte.2021.100274_b0435","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1681\/ASN.2017060664","article-title":"LDL receptor-related protein 2 (megalin) as a target antigen in human kidney anti-brush border antibody disease","volume":"29","author":"Larsen","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jcte.2021.100274_b0440","doi-asserted-by":"crossref","first-page":"R174","DOI":"10.1186\/ar754","article-title":"Autoantibodies to low-density- lipoprotein-receptor-related protein 2 (LRP2) in systemic autoimmune diseases","volume":"5","author":"Ooka","year":"2003","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jcte.2021.100274_b0445","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1053\/j.ajkd.2018.12.039","article-title":"Anti-LRP2 nephropathy with abundant IgG4-positive plasma cells: a case report","volume":"74","author":"Dinesh","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jcte.2021.100274_b0450","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.4049\/jimmunol.166.2.1360","article-title":"Anti-CD69 autoantibodies cross-react with low density lipoprotein receptor-related protein 2 in systemic autoimmune diseases","volume":"166","author":"Yu","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.jcte.2021.100274_b0455","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1515\/JPEM.2004.17.1.99","article-title":"Autoimmune thyroiditis in association with membranous nephropathy","volume":"17","author":"Illies","year":"2004","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.jcte.2021.100274_b0460","unstructured":"Jiang H, Wu G, Zhang W, Zhao Y, Xi X, Ruan C. Antiplatelet granule membrane protein (GMP-140) autoantibodies detected in plasma from patients with idiopathic thrombocytopenic purpura. Nouv Rev Fr Hematol 1993;35:487-90. N\/A."},{"key":"10.1016\/j.jcte.2021.100274_b0465","unstructured":"Zhang S, Dong J, Liu B. Evaluation and its clinical significance of anti- platelet granule membrane protein-140 autoantibodies and anticalmodulin antibody in patients with severe pregnancy-induced hypertension. Zhonghua Fu Chan Ke Za Zhi 1995;30:665-7. https:\/\/doi.org\/N\/A."},{"key":"10.1016\/j.jcte.2021.100274_b0470","series-title":"Werner & Ingbar\u2019s The Thyroid: a fundamental and clinical text","first-page":"162","article-title":"The thyrotropin receptor","author":"Vassart","year":"2013"},{"key":"10.1016\/j.jcte.2021.100274_b0475","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1210\/er.2015-1098","article-title":"TSH receptor cleavage into subunits and shedding of the A-Subunit; a molecular and clinical perspective","volume":"37","author":"Rapoport","year":"2016","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jcte.2021.100274_b0480","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0300-9084(99)80104-7","article-title":"The disulfide bond pattern between fragments obtained by the limited proteolysis of bovine thyroglobulin","volume":"81","author":"Veneziani","year":"1999","journal-title":"Biochimie"},{"key":"10.1016\/j.jcte.2021.100274_b0485","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.cell.2008.10.002","article-title":"Lrp4 is a receptor for agrin and forms a complex with MuSK","volume":"135","author":"Kim","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jcte.2021.100274_b0490","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3389\/fimmu.2020.00212","article-title":"Autoantibody specificities in myasthenia gravis; implications for improved diagnostics and therapeutics","volume":"11","author":"Lazaridis","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcte.2021.100274_b0495","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/00207454.2010.539307","article-title":"Frequency of autoimmune diseases in myasthenia gravis: a systematic review","volume":"121","author":"Mao","year":"2011","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.jcte.2021.100274_b0500","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/acn3.26","article-title":"LRP4 antibodies in serum and CSF from amyotrophic lateral sclerosis patients","volume":"1","author":"Tzartos","year":"2014","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.jcte.2021.100274_b0505","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/mus.25438","article-title":"Agrin and low-density lipoprotein-related receptor protein 4 antibodies in amyotrophic lateral sclerosis patients","volume":"55","author":"Rivner","year":"2017","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jcte.2021.100274_b0510","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.04287","article-title":"Synaptic plasticity and cognitive function are disrupted in the absence of Lrp4","volume":"3","author":"Gomez","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.jcte.2021.100274_b0515","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116701","article-title":"Lrp4 domains differentially regulate limb\/brain development and synaptic plasticity","volume":"10","author":"Pohlkamp","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcte.2021.100274_b0520","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/nn.4326","article-title":"Lrp4 in astrocytes modulates glutamatergic transmission","volume":"19","author":"Sun","year":"2016","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.jcte.2021.100274_b0525","doi-asserted-by":"crossref","first-page":"5347","DOI":"10.1523\/JNEUROSCI.0250-20.2020","article-title":"A role of low-density lipoprotein receptor-related protein 4 (LRP4) in astrocytic A\u03b2 clearance","volume":"40","author":"Zhang","year":"2020","journal-title":"J Neurosci"},{"key":"10.1016\/j.jcte.2021.100274_b0530","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/ncn3.105","article-title":"Presynaptic dysfunction caused by cerebrospinal fluid from a patient with the ataxic form of Hashimoto's encephalopathy","volume":"2","author":"Mitoma","year":"2014","journal-title":"Neurology and Clinical Neuroscience"},{"key":"10.1016\/j.jcte.2021.100274_b0535","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12311-015-0664-x","article-title":"Consensus paper: neuroimmune mechanisms of cerebellar ataxias","volume":"15","author":"Mitoma","year":"2016","journal-title":"Cerebellum"},{"key":"10.1016\/j.jcte.2021.100274_b0540","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.548469","article-title":"Autoantibodies targeting intracellular and extracellular proteins in autoimmunity","volume":"12","author":"Burbelo","year":"2021","journal-title":"Front Immunol."}],"container-title":["Journal of Clinical &amp; Translational Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214623721000260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214623721000260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:57:54Z","timestamp":1762005474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214623721000260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":108,"alternative-id":["S2214623721000260"],"URL":"https:\/\/doi.org\/10.1016\/j.jcte.2021.100274","relation":{},"ISSN":["2214-6237"],"issn-type":[{"value":"2214-6237","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amino acid sequence homology between thyroid autoantigens and central nervous system proteins: Implications for the steroid-responsive encephalopathy associated with autoimmune thyroiditis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical & Translational Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcte.2021.100274","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100274"}}